Azactam
Links shared publicly online about this topic
APP Pharmaceuticals Announces Approval And Launch Of First Generic Aztreonam For Injection, USP
medicalnewstoday.com — “APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc., (NASDAQ: APCVZ) announced that it has received approval from the U.S. Food and Drug Administra” View full resource at medicalnewstoday.com
Most Recently Shared on June 22, 2010 at 12:12 pm By:
MNT Infect Diseases Health News
APP Pharmaceuticals Announces Approval And Launch Of First Generic Aztreonam For Injection, USP http://mnt.to/3F98 #viruses #bacteria
APP Pharmaceuticals receives FDA approval to market Aztreonam for Injection, USP
news-medical.net — “APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc., announced today that it has received approval from the U.S. Food and Drug Administration to market Aztreonam for Injection, USP in two dosage strengths. Aztreonam is therapeutically equivalent to the reference-listed drug Azactam, which is marketed by Bristol-Myers Squibb.” View full resource at news-medical.net
Most Recently Shared on June 21, 2010 at 9:11 am By:
News-Medical.Net Health News and Oncology
Oncology News: APP Pharmaceuticals receives FDA approval to market Aztreonam for Injection, USP: APP Pharmaceutica... http://bit.ly/bI0bhA
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
MNT Infect Diseases
The latest infectious diseases / bacteria / viruses news published daily. Articles from research centers, universities and prestigious journals.
-
News-Medical.Net
Stay up to date with the latest Oncology news and research via News-Medical.Net
Advertisement
